Display options
Share it on

World J Nucl Med. 2011 Jan;10(1):14-9. doi: 10.4103/1450-1147.82114.

Strategy for bone metastases treatment in patients with impending cord compression or vertebral fractures: a pilot study.

World journal of nuclear medicine

N Rasulova, V Lyubshin, F Djalalov, K H Kim, L Nazirova, N Ormanov, D Arybzhanov

Affiliations

  1. Nuclear Medicine Department of Republic Specialized Center of Surgery, Republican Research Medical Centre of Emergency Medicine, Tashkent, Uzbekistan.

PMID: 22034578 PMCID: PMC3198037 DOI: 10.4103/1450-1147.82114

Abstract

Impending spinal cord compression and vertebral fractures are considered contraindications for radionuclide bone pain palliation therapy. However, most of the patients with widespread bone metastases already have weakened vertebral segments that may be broken. Therefore, local field external-beam radiotherapy or percutaneous vertebroplasty (VP) should be considered to improve the patient's quality of life and to institute subsequent appropriate treatment, including radionuclide therapy for bone pain palliation. The objective of this study was to develop a strategy for an effective treatment of bone metastases in patients with widespread bone metastases and intolerable pain, associated with impending cord compression or vertebral fractures. Eleven patients (5 females and 6 males, aged 32-62 years; mean age 53.8 ± 2.7 years) with multiple skeletal metastases from carcinomas of prostate (n = 3), breast (n = 3) and lung (n = 5) were studied. Their mean pain score measured on a visual analogue scale of 10 was found to be 8.64 ± 0.15 (range 8-9) and the mean number of levels with impending cord compression or vertebral fracture was 2.64 ± 0.34 (range 1-4). All patients underwent vertebroplasty and after 3-7 days received Sm-153 ethylene diamine tetra methylene phosphonic acid (EDTMP) therapy. Sm-153 EDTMP was administered according to the recommended standard bone palliation dose of 37 MBq/kg body weight. Whole body (WB) bone scan, computed tomography and magnetic resonance imaging (MRI) were performed before and after treatment in all patients. Pain relief due to stabilization of vertebrae after VP occurred within the first 12 hours (mean 4.8 ± 1.2 hours; range 0.5-12 hours), and the mean pain score was reduced to 4.36 ± 0.39 (range 2-6). Subsequent to Sm-153 EDTMP treatment, further pain relief occurred after 3.91 ± 0.39 days (range 2-6 days) and the pain score decreased to 0.55 ± 0.21 (range 0-2). The responses to treatment were found to be statistically significant (P < 0.0001). Based on the results on this limited patient population, we conclude that spinal stabilization using VP in patients with widespread bone metastases and impending cord compression is an effective way to decrease disability with pain and to facilitate subsequent systemic palliation of painful skeletal metastases by Sm-153 EDTMP therapy.

Keywords: Bone pain palliation; Sm-153 EDTMP; vertebroplasty

References

  1. Radiol Med. 2008 Feb;113(1):114-33 - PubMed
  2. Osteoporos Int. 2006;17(6):817-26 - PubMed
  3. Clin Orthop Relat Res. 1985 Jan-Feb;(192):222-7 - PubMed
  4. Spine (Phila Pa 1976). 2009 Oct 15;34(22 Suppl):S93-100 - PubMed
  5. Clin Orthop Relat Res. 2004 Sep;(426):49-53 - PubMed
  6. Cancer Treat Rev. 2001 Jun;27(3):165-76 - PubMed
  7. Spine (Phila Pa 1976). 1990 Jan;15(1):1-4 - PubMed
  8. Pain Pract. 2005 Dec;5(4):316-23 - PubMed
  9. Radiology. 1996 Aug;200(2):525-30 - PubMed
  10. Acta Orthop Scand. 1994 Apr;65(2):147-53 - PubMed
  11. Cancer. 2004 May 1;100(9):1776-85 - PubMed
  12. Cancer J. 2002 Mar-Apr;8(2):194-206 - PubMed
  13. AJNR Am J Neuroradiol. 2008 Apr;29(4):642-8 - PubMed
  14. Eur Spine J. 2003 Aug;12(4):356-60 - PubMed
  15. Radiology. 2004 Sep;232(3):846-53 - PubMed
  16. J Clin Oncol. 2002 May 1;20(9):2382-7 - PubMed
  17. Acta Oncol. 2003;42(5-6):620-33 - PubMed
  18. Neurosurg Focus. 2003 Nov 15;15(5):E11 - PubMed
  19. Bone. 1995 Aug;17(2 Suppl):101S-105S - PubMed
  20. Acta Radiol. 2006 May;47(4):369-76 - PubMed
  21. Eur Rev Med Pharmacol Sci. 2007 Mar-Apr;11(2):91-100 - PubMed
  22. Can Assoc Radiol J. 2006 Feb;57(1):13-21 - PubMed
  23. Rev Rhum Engl Ed. 1997 Mar;64(3):177-83 - PubMed
  24. Clin Orthop Relat Res. 2007 May;458:83-9 - PubMed
  25. Eur J Haematol. 2006 Jul;77(1):7-13 - PubMed
  26. Cancer. 1997 Oct 15;80(8 Suppl):1588-94 - PubMed
  27. Acta Radiol. 2007 Feb;48(1):89-95 - PubMed
  28. Clin Orthop Relat Res. 1982 Sep;(169):95-102 - PubMed
  29. Spine (Phila Pa 1976). 2009 Jun 1;34(13):E469-72 - PubMed
  30. Spine (Phila Pa 1976). 2004 Jul 1;29(13):1428-35; discusssion 1435 - PubMed
  31. Bone. 1999 Aug;25(2 Suppl):17S-21S - PubMed
  32. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1934-40 - PubMed
  33. Cardiovasc Intervent Radiol. 2008 Sep-Oct;31(5):937-47 - PubMed
  34. J Bone Joint Surg Am. 2009 Jun;91(6):1518-30 - PubMed
  35. J Neurosurg Spine. 2005 Oct;3(4):296-301 - PubMed
  36. BMC Cancer. 2011 Jan 24;11:29 - PubMed
  37. Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):494-8 - PubMed
  38. J Neurosurg Spine. 2008 Nov;9(5):493-501 - PubMed
  39. J Bone Joint Surg Am. 1986 Sep;68(7):1110-5 - PubMed
  40. Spine (Phila Pa 1976). 2001 Feb 1;26(3):298-306 - PubMed

Publication Types